Home
Conditions
Blood-Borne Infections

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,266 public trials 445 recruiting studies

Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in Uganda

NCT00122941

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Centre for International Health University of Bergen Bergen, Norway

Department of Paediatrics and Child Health, Mulago Hospital Kampala, Uganda

View Trial Details

Completed

Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y

NCT00696917

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Parkville, Victoria, Australia

GSK Clinical Trials Call Center Hradec Kralové, Czechia

GSK Clinical Trials Call Center München, Germany

GSK Clinical Trials Call Center Bari, Italy

View Trial Details

Completed

Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults

NCT00697242

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Vienna, Austria

GSK Clinical Trials Call Center Ghent, Belgium

GSK Clinical Trials Call Center Hvidovre, Denmark

GSK Clinical Trials Call Center Reykjavik, Iceland

View Trial Details

Completed

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

NCT00696891

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Wilrijk, Belgium

GSK Clinical Trials Call Center Toronto, Canada

GSK Clinical Trials Call Center Gothenburg, Sweden

View Trial Details

Completed

Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different Adjuvants

NCT00697125

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Ghent, Belgium

View Trial Details

Completed

Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).

NCT00697216

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Brussels, Belgium

GSK Clinical Trials Call Center Copenhagen, Denmark

View Trial Details

Completed

Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different Schedules

NCT00697229

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: GSK Clinical Trials Call Center Wilrijk, Belgium

View Trial Details

Completed

AIDS Vaccine Study Comparing Immunogenicity and Safety of 3 Doses of Lipopeptides Versus Placebo in Non Infected HIV Volunteers

NCT00121758

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: CIC de Vaccinologie Cochin Pasteur Paris, France

View Trial Details

Completed

Male Circumcision and HIV Rates in Kenya

NCT00059371

Conditions: Blood-Borne Infections, Communicable Diseases, Disease Attributes, +14 more
Locations: UNIM Clinic Kisumu, Kisumu County, Kenya

View Trial Details

Completed

Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel

NCT00561496

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

Advances in Health, Inc Houston, Texas, United States

Profamilia Santo Domingo, Dominican Republic

View Trial Details

Blood-Borne Infections

Blood-Borne Infections trial results

Related conditions